Ever accidentally miss a meal dose or underestimate a carb count? Life with diabetes can be unpredictable.
Now there's an insulin pump system designed with Meal Detection™ technology* that automatically adjusts and corrects† sugar levels every 5 minutes.§
For those times when you forget to plan ahead. Just like in real life.
The MiniMed™ 780G system is the only insulin pump system designed with Meal Detection™ technology, an advanced feature that uses current and past sugar trends to detect a missed meal dose,* and then it delivers stronger auto corrections without any work needed from you.
Insulin delivery systems
|Auto correction bolus||Every 5 mins
100% correction bolus∆
|Every 5 mins
|Every 60 mins
60% correction bolus
|Meal detection™ technology|
|Automated basal delivery every 5 minutes§|
|Compatible infusion set approved for up to 7-day wear|
|Flexible glucose target as low as 100 mg/dL|
|Available in multiple languages — English, Spanish, simplified Chinese|
|Personalized insights program based on glucose data|
|CGM transmitter lifespan||1 year||3 months||3 months|
We will get started on determining your insurance or pharmacy coverage. A member of our team will reach out to you for additional information. If you have questions, please contact us at 888-882-8602 (M-F 9 AM-6 PM CT).
If you are using an in-warranty pump from another company, you may upgrade to our latest technology for up to $499.1 And, if you are using an in-warranty transmitter from another company, you may upgrade to our latest transmitter technology for up to $100.2
* Taking a bolus 15 – 20 minutes before a meal helps to keep blood sugar levels under control after eating.
† Refers to auto correct, which provides bolus assistance. Can deliver all auto correction doses automatically without user interaction, feature can be turned on and off.
§ Refers to SmartGuard™ feature. Individual results may vary.
Φ For a list of compatible devices, visit http://bit.ly/CheckDevices.
∆ Up to 8% of the total daily dose delivered over 45 minutes. Comparison chart based on publicly available information.
1. General Pump Pathway Program
2. Competitor Continuous Glucose Monitor (CGM) Pathway Program
The MiniMed™ 780G system is intended for continuous delivery of basal insulin at selectable rates, and the administration of insulin boluses at selectable amounts for the management of type 1 diabetes mellitus in persons seven years of age and older requiring insulin as well as for the continuous monitoring and trending of glucose levels in the fluid under the skin. The MiniMed™ 780G system includes SmartGuard™ technology, which can be programmed to automatically adjust insulin delivery based on the continuous glucose monitoring (CGM) sensor glucose values and can suspend delivery of insulin when the sensor glucose (SG) value falls below or is predicted to fall below predefined threshold values.
The Medtronic MiniMed™ 780G system consists of the following devices: MiniMed™ 780G insulin pump, the Guardian™ 4 transmitter, the Guardian™ 4 sensor, One-press serter, the Accu-Chek™ Guide Link blood glucose meter, and the Accu-Chek™ Guide test strips. The system requires a prescription from a healthcare professional.
The Guardian™ 4 sensor is intended for use with the MiniMed™ 780G system and the Guardian 4 transmitter to monitor glucose levels for the management of diabetes. The sensor is intended for single use and requires a prescription. The Guardian™ 4 sensor is indicated for up to seven days of continuous use.
The Guardian™ 4 sensor is not intended to be used directly to make therapy adjustments while the MiniMed™ 780G is operating in manual mode. All therapy adjustments in manual mode should be based on measurements obtained using a blood glucose meter and not on values provided by the Guardian™ 4 sensor. The Guardian™ 4 sensor has been studied and is approved for use in patients ages 7 years and older and in the arm insertion site only. Do not use the Guardian™ 4 sensor in the abdomen or other body sites including the buttocks, due to unknown or different performance that could result in hypoglycemia or hyperglycemia.
WARNING: Do not use the SmartGuard™ feature for people who require less than 8 units or more than 250 units of total daily insulin per day. A total daily dose of at least 8 units, but no more than 250 units, is required to operate in the SmartGuard™ feature.
WARNING: Do not use the MiniMed™ 780G system until appropriate training has been received from a healthcare professional. Training is essential to ensure the safe use of the MiniMed™ 780G system.
WARNING: Do not use SG values to make treatment decisions, including delivering a bolus, while the pump is in Manual Mode. When the SmartGuard™ feature is active and you are no longer in Manual Mode, the pump uses an SG value, when available, to calculate a bolus amount. However, if your symptoms do not match the SG value, use a BG meter to confirm the SG value. Failure to confirm glucose levels when your symptoms do not match the SG value can result in the infusion of too much or too little insulin, which may cause hypoglycemia or hyperglycemia.
Pump therapy is not recommended for people whose vision or hearing does not allow for the recognition of pump signals, alerts, or alarms. The safety of the MiniMed™ 780G system has not been studied in pregnant women, persons with type 2 diabetes, or in persons using other anti-hyperglycemic therapies that do not include insulin. For complete details of the system, including product and important safety information such as indications, contraindications, warnings and precautions associated with system and its components, please consult https://www.medtronicdiabetes.com/important-safety-information#minimed-780g and the appropriate user guide at https://www.medtronicdiabetes.com/download-library